A review of all complaints associated with the creatinine assay (list number 3l81, lot number 32869un18) and a review for complaint trends and capa for the list number was performed.The review did not identify any trends associated with this issue.Historical performance of the reagent lot was evaluated using world wide data from abbott link.The patient data was analyzed and compared to an established control limit.This evaluation indicated that the patient median result for this lot is within the established control limits which indicates that the lot is performing acceptably and comparable to other lots in the field.Additionally, labeling was reviewed and adequately addresses the issue under review.Based on the available information, no product deficiency was identified.
|